Accord Healthcare Recalls Levothyroxine Sodium Tablets, 100 mcg, Over Subpotency
The FDA's enforcement report lists a Class II recall of specific lots of the prescription thyroid drug, distributed nationwide, for a subpotent drug.
Recalls & Safety Alerts in Raleigh, North Carolina
Every recalls & safety alerts report published for Raleigh, North Carolina, newest first.
Accord Healthcare Recalls Levothyroxine Sodium Tablets, 88 mcg, Over Subpotency
The FDA's enforcement report lists a Class II recall of 1000-count prescription bottles distributed nationwide, with the firm's database showing no other enforcement action.
Accord Healthcare Recalls Levothyroxine Tablets Over Subpotency
FDA classifies nationwide recall of 112 mcg levothyroxine sodium tablets as Class II due to subpotent drug.
FDA Closes Recall of Accord Healthcare Levothyroxine Tablets
The FDA has closed the Class II recall of certain levothyroxine sodium tablets due to subpotency, according to an agency enforcement report.
Accord Healthcare Recalls Levothyroxine Sodium Tablets Due to Subpotency
FDA classifies recall of certain 200 mcg levothyroxine sodium tablets as Class II, citing subpotent drug.
Accord Healthcare Recalls Levothyroxine Tablets Due to Subpotency
FDA Class II recall of certain lots of Levothyroxine Sodium Tablets, 137 mcg, distributed nationwide.
FDA Reports Recall of Accord Healthcare Levothyroxine Tablets
The FDA enforcement report dated September 2, 2026, lists a Class II recall of a specific lot of levothyroxine sodium tablets due to subpotency.
Accord Healthcare Recalls Levothyroxine Tablets Over Subpotency
FDA classifies recall of certain 150 mcg levothyroxine sodium tablets as Class II due to subpotency.
FDA Closes Recall of Accord Healthcare Levothyroxine Tablets
The FDA has closed the Class II recall of certain levothyroxine sodium tablets distributed nationwide.
Accord Healthcare Recalls Levothyroxine Sodium Tablets Due to Subpotency
FDA Class II recall of two lots of levothyroxine sodium tablets distributed nationwide.
Accord Healthcare Recalls Levothyroxine Sodium Tablets Due to Subpotency
FDA Class II recall of certain 125 mcg levothyroxine tablets distributed nationwide.
Accord Healthcare Recalls Levothyroxine Sodium Tablets Due to Subpotency
FDA Class II recall of certain 25 mcg levothyroxine tablets distributed nationwide.
FDA Class I Recall Issued for Optiray Contrast Agent Due to Particulate Matter
Liebel-Flarsheim Company LLC recalls 3,486 vials of Optiray Imaging Bulk Package-350 after FDA classifies action as Class I.